Health Care

Theranos Inc. withdrew its request for emergency clearance of a Zika-virus blood test after federal regulators found that the company didn't include proper patient safeguards in a study of the new test, said people familiar with the matter.

A university in Florida is working hard to fight back against the Zika virus, which has been a concern for citizens of the state.

A Pennsylvania drug company announced Monday that it has launched a clinical trial of a Zika vaccine in Puerto Rico, the part of the U.S. hardest hit by the mosquito-borne virus.

Inovio Pharmaceuticals announced Monday it’s launching a ground-breaking clinical trial of a Zika vaccine in Puerto Rico.

As consumers and legislators try to navigate a myriad of healthcare-related uncertainties, one thing remains clear: Whether you hope the law gets scrapped or see the possibility for repair, the Affordable Care Act is as divisive an issue now as it was in 2010.

Opinion: EpiPen 'villain' is a shrewd executive with all the means and morality of a modern day politician.

Mylan said on Monday it would launch the first generic to its allergy auto-injector EpiPen at a discount of more than 50 percent to the branded product's list price.

Rx Savings Solutions CEO Michael Rea said there’s an alternative to the EpiPen that delivers the same dose and active ingredient as Mylan’s device.

St. Jude Medical Inc. on Friday denied allegations made by a research firm that its pacemakers and other heart devices were vulnerable to hacking and other cybersecurity threats.

Cars that wirelessly talk to each other are finally ready for the road, creating the potential to dramatically reduce traffic deaths, improve the safety of self-driving cars and someday maybe even help solve traffic jams, automakers and government officials say.

Mazda Motor Corp. is recalling more than 190,000 CX-7 sport utility vehicles because of a potentially dangerous steering control defect.

More than 30 million children's wristbands distributed at McDonald's restaurants are being recalled because they can cause skin irritation or burns.

Carl Icahn has recently discussed selling his stake in Herbalife to a group including the company's arch-nemesis William Ackman.